"Colorado Heart Doctors – South Denver Cardiology Heart Center From the award-winning team of cardiologists that make up South Denver Cardiology Associates and comprehensive support staff to the state-of-the-art facility that was custom built to our unique specifications, every part of your experience as a guest at our center has been designed with peace and healing in mind. When you visit the Heart Center, your physician will discuss exercise, nutrition, and stress-reduction with the same level of focus as medication and diagnostic tests as they design a plan tailored to your personal needs."

During the past decade, South Denver Cardiology Associates PC conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 32 clinical trials were completed, i.e. on average, 68.1% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 24 clinical trials were completed. i.e. 126.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "South Denver Cardiology Associates PC" #1 sponsor was "Abbott Medical Devices" with 17 trials, followed by "Boston Scientific Corporation" with 7 trials sponsored, "Actelion" with 4 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored and "Bristol-Myers Squibb" with 3 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "South Denver Cardiology Associates PC" #1 collaborator was "Medpace, Inc." with 3 trials as a collaborator, "Duke Clinical Research Institute" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "AFTx, Inc" with 1 trials as a collaborator and "AcitGraph" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "South Denver Cardiology Associates PC" are "Heart Failure" (11 trials), "Coronary Artery Disease" (7 trials), "Atrial Fibrillation" (6 trials), "Pulmonary Arterial Hypertension" (5 trials) and "Stroke" (5 trials). Many other conditions were trialed in "South Denver Cardiology Associates PC" in a lesser frequency.

Most popular intervention types in "South Denver Cardiology Associates PC" are "Drug" (39 trials), "Device" (34 trials), "Other" (8 trials), "Behavioral" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "Apixaban" (3 trials), "Empagliflozin" (2 trials), "Etripamil" (2 trials) and "Oral treprostinil" (2 trials). Other intervention names were less common.

The vast majority of trials in "South Denver Cardiology Associates PC" are 70 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "South Denver Cardiology Associates PC". undefined are not yet recruiting, 11 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in South Denver Cardiology Associates PC, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in South Denver Cardiology Associates PC, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 27 trials that are defined as “Not Applicable".